# The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

> **NCT01636505** · PHASE3 · UNKNOWN · sponsor: **European Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Embryo's Genetic and Chromosomal Quality

## Interventions

- **DRUG:** ghrh antagonist (cetrotide/orgalutran)
- **DRUG:** gnrh agonist (suprefact)

## Key facts

- **NCT ID:** NCT01636505
- **Lead sponsor:** European Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-02
- **Final completion:** 2013-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01636505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01636505, "The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01636505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*